Cargando…
Heparin-induced thrombocytopenia during renal replacement therapy in the intensive care unit
Whereas some 30% to 50% of patients admitted to the intensive care unit develop thrombocytopenia during their stay, the incidence of heparin-induced thrombocytopenia (HIT) remains low, at around 0.3% to 0.5%. Lasocki and colleagues prospectively tested patients with premature clotting of the hemofil...
Autor principal: | Davenport, Andrew |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2481467/ https://www.ncbi.nlm.nih.gov/pubmed/18620549 http://dx.doi.org/10.1186/cc6914 |
Ejemplares similares
-
Extracorporeal renal replacement therapy in patients with heparin-induced thrombocytopenia
por: Bekers-Anchipolovskis, M, et al.
Publicado: (2009) -
Anticoagulation during continuous renal replacement therapy with lepirudin in patients with heparin-induced thrombocytopenia
por: Schroeder, T, et al.
Publicado: (2005) -
Orgaran(® )use in intensive care unit patients with heparin-induced thrombocytopenia and acute renal failure
por: Magnani, H, et al.
Publicado: (2007) -
Commentary: Are platelet patterns repeated in delayed heparin-induced thrombocytopenia/heparin-induced thrombocytopenia and thrombosis syndrome after cardiac surgery?
por: Kramer, Robert S., et al.
Publicado: (2020) -
Fondaparinux in heparin‐induced thrombocytopenia: A decade's worth of clinical experience
por: Schindewolf, Marc
Publicado: (2018)